Archives
Review: Classic and exertional heatstroke.
15 Feb, 2022 | 08:43h | UTCClassic and exertional heatstroke – Nature Reviews Disease Primers (if the link is paywalled, try this one)
Commentary on Twitter
Cooling of patients with #heatstroke includes evaporative strategies and conductive methods that aim to establishing the largest possible temperature gradient between the body core and the skin https://t.co/i53jyJBTl5 pic.twitter.com/tofUjiDJYG
— Nature Reviews Disease Primers (@DiseasePrimers) February 8, 2022
Systematic Review: Arthroplasties for hip fracture in adults.
15 Feb, 2022 | 08:41h | UTCArthroplasties for hip fracture in adults – Cochrane Library
Summary: Hip replacement surgery in adults – Cochrane Library
Author Interview: Interview with authors of Hip Fracture reviews – Cochrane Library
A large cohort of patients with nephrotic syndrome showed the risk of arterial thromboembolism (HR = 3.11), venous thromboembolism (HR = 7.11), and bleeding (HR = 4.02) was greatly increased after adjusting for confounders.
15 Feb, 2022 | 08:47h | UTCRisk of arterial thromboembolism, venous thromboembolism, and bleeding in patients with nephrotic syndrome: A population-based cohort study – American Journal of Medicine (link to abstract – $ for full-text)
Data Review: How many people die from air pollution?
15 Feb, 2022 | 08:37h | UTCData Review: How many people die from air pollution? – Our World in Data
Related:
New WHO Global Air Quality Guidelines aim to save millions of lives from air pollution.
1.8 million excess deaths attributable to urban air pollution in 2019, modelling study suggests.
Air Pollution Associated with New Causes of Hospital Admissions
Ambient Particulate Air Pollution and Daily Mortality in 652 Cities
Air Pollution and Estimated Life Expectancy Loss
A clinician’s guide to Artificial Intelligence (AI): why and how primary care should lead the health care AI revolution.
15 Feb, 2022 | 08:38h | UTCRelated:
Primer for artificial intelligence in primary care.
A Clinician’s Guide to Artificial Intelligence: How to Critically Appraise Machine Learning Studies
Review | AI and the cardiologist: when mind, heart and machine unite.
Review: Artificial intelligence in health and medicine.
Opinion | AI-facilitated health care requires education of clinicians
Welcoming new guidelines for AI clinical research
Why randomized controlled trials matter and the procedures that strengthen them.
15 Feb, 2022 | 08:39h | UTCWhy randomized controlled trials matter and the procedures that strengthen them – Our World in Data
Ending the evidence gap for pregnancy, HIV and co-infections: ethics guidance from the PHASES project.
15 Feb, 2022 | 08:35h | UTC
Cluster RCT: An educational safety-promoting program in neonatal intensive care units reduced the rate of adverse events.
15 Feb, 2022 | 08:27h | UTCAn educational programme in neonatal intensive care units (SEPREVEN): a stepped-wedge, cluster-randomised controlled trial – The Lancet (link to abstract – $ for full-text)
Commentary on Twitter
Patients in neonatal intensive care units (NICUs) are at high risk of adverse events.
A stepped-wedge, cluster-RCT by Laurence Caeymaex & colleagues found a multiprofessional safety-promoting training programme in NICUs reduced the rate of such events. https://t.co/plmKBCOLOu pic.twitter.com/NdR9SiAqUI
— The Lancet (@TheLancet) January 26, 2022
M-A: Single antiplatelet therapy should be used after transcatheter aortic valve implantation in patients without indication for anticoagulation.
15 Feb, 2022 | 08:32h | UTCComparing Single- and Dual-Antiplatelet Therapies After Transcatheter Aortic Valve Implantation – The Annals of Thoracic Surgery (link to abstract – $ for full-text)
Related:
Efficacy, durability, and safety of intravitreal Faricimab up to every 16 weeks for neovascular age-related macular degeneration: two randomized, double-masked, phase 3, non-inferiority trials.
15 Feb, 2022 | 08:29h | UTCEfficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials – The Lancet (link to abstract – $ for full-text)
Commentary: Trials Show Promise for Intravitreal Faricimab in Retinal Disease – HealthDay
Futility in Transcatheter Aortic Valve Implantation: A Search for Clarity.
15 Feb, 2022 | 08:26h | UTC
Pfizer and FDA pull back from plan to expedite review of Covid-19 vaccine in children under 5.
13 Feb, 2022 | 22:51h | UTCPfizer and FDA pull back from plan to expedite review of Covid-19 vaccine in young children – STAT
See also:
COVID-19 vaccine for kids under 5 delayed as Pfizer extends trial – CIDRAP
Pfizer postpones FDA request for Covid vaccine for kids under 5 – NBC News
WHO’s new International Classification of Diseases (ICD-11) comes into effect.
13 Feb, 2022 | 22:56h | UTCNews Release: WHO’s new International Classification of Diseases (ICD-11) comes into effect – World Health Organization
See also:
Commentary on Twitter
🆕 The latest update for the 11th Revision of the International Classification of Diseases (ICD-11) is now online!#ICD11 is a 'common language' for health professionals to share standardized health information around the world.
Learn more https://t.co/M2yu9md9fm pic.twitter.com/jv2IbEkD5u— World Health Organization (WHO) (@WHO) February 11, 2022
Novavax says protein vaccine works for kids as young as 12.
13 Feb, 2022 | 22:54h | UTCNovavax says protein vaccine works for kids as young as 12 – Associated Press
Press Release: Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial
Related:
Opinion | The mRNA vaccines are extraordinary, but Novavax is even better.
RCT: Novavax vaccine is 49.4% effective against B.1.351 SARS-CoV-2 variant.
New COVID-19 vaccines: here’s how the promising Novavax and Johnson & Johnson jabs work
Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant
Covid-19: What do we know about omicron sublineages?
13 Feb, 2022 | 22:42h | UTCCovid-19: What do we know about omicron sublineages? – The BMJ
Related:
We regret to inform you that we are now discussing subvariants – Vox
Sudden rise of more transmissible form of Omicron catches scientists by surprise.
Omicron’s sister variant spreads faster. So why did the one we call Omicron hit first?
BA.2 is like Omicron’s sister. Here’s what we know about it so far – The Conversation
Commentary on Twitter
In November 2021 WHO designated omicron a variant of concern. With its sublineage BA.2 now widespread, @emahase_ looks at what science has found out about the variant and its three (so far) variations https://t.co/HjBZSwCATW
— The BMJ (@bmj_latest) February 13, 2022
Conflicting reports raise questions about whether any monoclonals work against Omicron’s sister variant.
13 Feb, 2022 | 22:49h | UTCRelated:
FDA halts use of antibody drugs that don’t work vs. Omicron.
ERS statement on Long COVID-19 follow-up.
13 Feb, 2022 | 22:48h | UTCEuropean Respiratory Society Statement on Long COVID-19 Follow-Up – European Respiratory Review
First research definition for ‘Long COVID’ in kids and young people formally agreed.
13 Feb, 2022 | 22:45h | UTCNews Release: First research definition for ‘Long COVID’ in kids and young people formally agreed – BMJ
Original Article (preprint): Long COVID (Post-COVID-19 condition) in Children: a modified Delphi Process – Archives of Disease in Childhood
Commentaries:
Long covid: “Holistic” approach is best, given range of symptoms, say researchers – The BMJ
Related:
Editorial | Long covid in children and adolescents – “Risk appears low, but many questions remain”.
Review: Long COVID symptoms in children rarely persist beyond three months.
Special Issue: Evidence-based strategies for better antibiotic prescribing in primary care.
13 Feb, 2022 | 22:40h | UTCEditorial: Antibiotic stewardship – Australian Journal of General Practice
Evidence-based strategies for better antibiotic prescribing – Australian Journal of General Practice
RCT: Effects of a 6-month, low-carbohydrate diet on glycemic control, body composition, and cardiovascular risk factors in patients with type 2 diabetes.
13 Feb, 2022 | 22:35h | UTC
RCT: Primary Norfloxacin prophylaxis prevents bacterial infections in patients with acute-on-chronic liver failure.
13 Feb, 2022 | 22:37h | UTCPrimary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure: A Placebo-Controlled Double-Blind Randomized Trial – The American Journal of Gastroenterology (link to abstract – $ for full-text)
WHO Guideline: Hypertension pharmacological treatment in adults.
13 Feb, 2022 | 22:23h | UTC
2022 SCCM Guidelines on prevention and management of pain, agitation, neuromuscular blockade, and delirium in critically ill pediatric patients with consideration of the ICU environment and early mobility.
13 Feb, 2022 | 22:19h | UTC
Commentary on Twitter
New in #PANDEM guidelines for infants & children: guidance on nonpharmacological interventions that can lead to better outcomes:
✅ Music
✅ Physical
✅ Occupational
✅ Child life
What interventions have worked well for you?
Guidelines: https://t.co/lMfFsiEPeV#SCCMSoMe #PedsICU pic.twitter.com/BLksVV0pNo— SCCM (@SCCM) February 4, 2022
AAST Consensus: Rhabdomyolysis.
13 Feb, 2022 | 22:21h | UTC
FIMS / EFSMA Joint position statement on the International Olympic Committee framework on fairness, inclusion and non-discrimination based on gender identity and sex variations.
13 Feb, 2022 | 22:17h | UTCOriginal Guidance: IOC Framework on fairness, inclusion and non-discrimination on the basis of gender identity and sex variations – International Olympic Committee
Commentary: International Olympic Committee transgender guidance criticised by medical experts – BBC
Commentary on Twitter
You do not have to agree with all content in this position statement. But surely we can agree that we need further debate and discussion (and consultation with all stakeholders) to protect the rights of all athletes. #OpenAccess ➡️ https://t.co/xIfnsyk7FV#Diversity #Inclusion pic.twitter.com/2c9S8lGCoa
— BMJ Open Sport & Exercise Medicine (@BMJOpenSEM) January 20, 2022


